Bone Marrow TransplantationBone MarrowTransplantation, HomologousHematopoietic Stem CellsBone Marrow CellsHematopoietic Stem Cell TransplantationGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationTransplantation ConditioningBone and BonesLeukemiaAnemia, AplasticTransplantation ChimeraHematopoiesisGraft SurvivalTissue DonorsLiver TransplantationBusulfanHistocompatibility TestingBone Marrow PurgingHistocompatibilityStem CellsMice, Inbred C57BLTransplantation, IsogeneicCyclophosphamideHematologic NeoplasmsStem Cell TransplantationBone Marrow DiseasesRecurrenceRadiation ChimeraKidney TransplantationColony-Forming Units AssayLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCombined Modality TherapyTreatment OutcomeTime FactorsHepatic Veno-Occlusive DiseaseImmunosuppressive AgentsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationAntigens, CD34Graft RejectionCell DifferentiationTransplantation ImmunologyLeukemia, MyeloidBone RemodelingSevere Combined ImmunodeficiencyHematopoietic Stem Cell MobilizationLymphocyte DepletionAcute DiseaseBone Marrow NeoplasmsImmunosuppressionMyelodysplastic SyndromesRetrospective StudiesT-LymphocytesGraft vs Host ReactionHematologic DiseasesLymphoma, Non-HodgkinHLA AntigensFlow CytometryLeukocyte TransfusionSurvival AnalysisChimeraHeart TransplantationCell LineageGraft vs Leukemia EffectCells, CulturedLymphocyte TransfusionGranulocyte Colony-Stimulating FactorCyclosporineCord Blood Stem Cell TransplantationGraft vs Tumor EffectLung TransplantationCytomegalovirus InfectionsAntineoplastic Combined Chemotherapy ProtocolsChimerismActuarial AnalysisSurvival RateFollow-Up StudiesBone DensityCell SeparationPancytopeniaSpleenOrgan TransplantationNuclear FamilyMice, KnockoutCarmustineCytarabineLeukocyte CountDisease-Free SurvivalMice, Inbred BALB CMelphalanPeripheral Blood Stem Cell TransplantationMultiple MyelomaLymphomaGranulocytesImmunophenotyping